Concepedia

Christopher H. van Dyck

CH

126

Publications

21.3K

Citations

60

H-Index

1994

Active since

Affiliations

Yale University(Current)

VA Connecticut Healthcare System

University of California San Diego

Washington University in St. Louis

Emory University

Christopher H. van Dyck is an author at Yale University specializing in medicine, neuroscience, and neurology.

ORCID

Top concepts

Publications per year

1994–2024

126

Publications

126

Lecanemab in Early Alzheimer’s Disease

Christopher H. van Dyck, Chad J. Swanson, Paul Aisen et al. · New England Journal of Medicine · 2022 · 4.7K citations · Full text

Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment

Ronald Petersen, Ronald G. Thomas, Michael Grundman et al. · New England Journal of Medicine · 2005 · 1.8K citations · Full text

Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease

Samantha Budd Haeberlein, Paul Aisen, Frederik Barkhof et al. · The Journal of Prevention of Alzheimer s Disease · 2022 · 1.2K citations · Full text

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.

Ruth A. Mulnard, Carl W. Cotman, Claudia H. Kawas et al. · PubMed · 2000 · 985 citations · Full text

A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease

Raymond Scott Turner, Ronald G. Thomas, Suzanne Craft et al. · Neurology · 2015 · 671 citations · Full text

Rows per page

1–5 of 126